Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).
The global Mitomycin C market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Kyowa-kirin
Intas Pharmaceuticals
Teva
Bristol-Myers Squibb
Aspen
Speciality European Pharma
Alkem Laboratories
Varifarma
APOGEPHA
Major applications as follows:
Cancer Treatment
Ophthalmic Use
Others
Major Type as follows:
2 Mg
10 Mg
40 Mg
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Content
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of End-Use
1.1.4 Scope of Product Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
Fig Global Mitomycin C Market Size and CAGR 2015-2019 (Million USD)
Fig Global Mitomycin C Market Size and CAGR 2015-2019 (Volume)
Fig Global Mitomycin C Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Mitomycin C Market Forecast and CAGR 2020-2025 (Volume)
Summary: Get latest Market Research Reports on Mitomycin C. Industry analysis & Market Report on Mitomycin C is a syndicated market report, published as Global Mitomycin C Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of Mitomycin C market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.